[6] Brian Druker was named the director of the then OHSU Cancer Institute in 2007.
[8][9] The Cancer Biology program focuses on tumorigenesis, signal transduction, and the tumor microenvironment.
Susan Flocke and Kerri Winters-Stone lead the Cancer Prevention and Control research program, which explores cancer prevention and risk reduction, screening and early detection, and survivorship.
[11] The Quantitative Oncology program focuses on technology development, molecular characterization, and systems biology.
[12] The fourth research program, Translational Oncology, has themes of target validation and high-impact interventions.